Lok Sabha Question No. 406 (STARRED), answered on 2018-03-23
Subject: Production of Vaccines
Ministry: HEALTH AND FAMILY WELFARE
Asked by: SHOBHA KARANDLAJE

## GOVERNMENT OF INDIA MINISTRY OF HEALTH AND FAMILY WELFARE DEPARTMENT OF HEALTH AND FAMILY WELFARE

## LOK SABHA STARRED QUESTION NO. 406 TO BE ANSWERED ON THE 23 RD MARCH, 2018 PRODUCTION OF VACCINES

## *406. KUMARI SHOBHA KARANDLAJE:

Will the Minister of HEALTH AND FAMILY WELFARE be pleased to state:

- (a)  whether  the  Government  proposes  to  take  steps  to  increase  productio vaccines by the Public Sector Undertakings (PSUs) under his Ministry to en undisrupted supply of vaccines and if so, the details thereof;
- (b) whether the private sector accounts for over 90 per cent of the require essential vaccines in the country even though three PSUs also manufacture and if so, the details thereof;
- (c)  whether  the  country's  Universal  I mmunization  Programme  (UIP)  is  largely dependent on the private sector, with PSU's share being miniscule or nil during 2014- 15 and 2015 - 16 and if so, the details thereof; and
- (d) the steps taken by the Government to upgrade the facilities in PSUs so the dependency on private vaccine manufacturing units can be reduced?

## ANSWER THE MINISTER OF HEALTH AND FAMILY WELFARE ( SHRI JAGAT PRAKASH NADDA )

- (a)to ( d) : A Statement is laid on the Table of the House.

## STATEMENT REFERRED TO IN REPLY TO LOK SABHA STARRED QUESTION NO. 406* FOR 23 RD MARCH, 2018

(a) to (d): Yes. The Government of India has approved upgradation the projects of the following Public Sector Vaccine Manufacturing Units with increase annual installed capacity: -

| S.No   | Name of Institute                   | Vaccines being produced            |
|--------|-------------------------------------|------------------------------------|
| (i)    | Central Research Kasauli            | Diphtheria Pertussis Tetanus (DPT) |
| (i)    | Institute,                          | Diphtheria Tetanus(DT)             |
| (i)    |                                     | Tetanus Toxoide (TT)               |
| (ii)   | BCG VL, Guindy                      | Bacillus Calmette Guerin (BCG)     |
| (iii)  | Pasteur Institute of India, Coonoor | Diphtheria Pertussis Tetanus (DPT) |
| (iii)  |                                     | Diphtheria Tetanus(DT)             |
| (iii)  |                                     | Tetanus Toxoide (TT)               |

CRI, Kasauli ,has already started functioning after up - gradation. BCG VL Guindy has also produced the consistency batches of BCG Vaccine and its quality testing is underway at Central Drug Laboratory, Kasauli. clearing testing protocols, BCG VL, Guindy ,will supply 45 - 50 lakh doses of BCG  Vaccines  per  month  from  August,  2018  on wards.  The  up - gradation project of Pasteur Institute of India is nearing completion and the pro of trial batches will commence by August, 2018.

The Government is not solely dependent on the private sector for vaccines  being  produced  by  PSUs.  How ever,  the  major  requirement  of remaining vaccines under Universal Immunization Programme(UIP) is being met  by  private  sector.  With  the  induction  of  Pentavalent  Vaccine Immunization  Programme,  the  requirement  of  DPT  Vaccine has reduced significantly. The status of production & supply of the vaccines manufactured  by  Public  Sector  Vaccine  Manufacturing  Institutes    duri 2014- 15 and 2015 - 16 are as under: -

| Name of Product   | 2014- 15   | 2014- 15   | 2015- 16   | 2015- 16   |
|-------------------|------------|------------|------------|------------|
|                   | Production | Supply     | Production | Supply     |
| DPT (Doses)       | 64.91 lakh | 17.52lakh  | 52.86 lakh | 66.00 lakh |
| TT (Doses)        | 46.68 lakh | 34.50 lakh | 76.98 lakh | 42.00 lakh |

In addition, Government has approved establishment of Project of Natio Importance namely  Integrated  Vaccine  Complex  (IVC)  as  a  subsidiary  o HLL  Life  Care  Ltd.  with  a  c ost  of  Rs.594  Crores.  On  completion  of  the project, IVC would produce Pentavalent Vaccine BCG, Measles, Hepatitis Human Rabies and Japanese Encephalitis Vaccines. As per policy decisio CRI, Kasauli and PII, Coonoor will supply 75% of Bulk Production of DPT components to IVC for production of Pentavalent Vaccine. After operationalization, IVC Chengalpattu  will meet the major chunk requirement of identified vaccines for it. After utilization of full c the  Public  Sector  Vaccine  Manufacturing  I nstitutes,  the  dependency  on private manufacturing units will be reduced considerably.

*********